Navigation Links
Chimerix Initiates a Multi-dose Clinical Trial of the Company's Lead Compound, CMX001, for the Treatment for Smallpox Infection
Date:12/11/2007

RESEARCH TRIANGLE PARK, N.C., Dec. 11 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally available antiviral therapeutics, announced today that the Company has initiated a multi-dose trial with its lead drug candidate, CMX001, an oral treatment for smallpox infection. This trial will study the pharmacokinetics and safety of three doses of the drug given to healthy volunteers.

"The high oral availability demonstrated by CMX001 in the Phase I trial has validated the utility of the company's lipid technology, ProLipTag(TM) and creates optimism for the potential of this drug candidate," said Dr. George Painter, Chimerix President and CEO. "In addition to smallpox, we believe that CMX001 has great potential in treating other serious infections such as human papillomavirus and cytomegalovirus."

CMX001 is being developed for the treatment of smallpox infection and other double stranded DNA virus infections that cause significant human morbidity and mortality. A safe, orally active antiviral drug for smallpox is needed to provide a means of treating people who become ill post exposure to the disease or who cannot be vaccinated. Chimerix has previously demonstrated that single doses of CMX001 provided excellent drug exposure and were well tolerated in healthy volunteers. CMX001 is being developed for smallpox under a licensing agreement with Gilead Sciences, Inc. The work is partially funded by a $36.1 million grant awarded to the company by the National Institutes of Allergy and Infectious Disease.

About Chimerix

Chimerix, Inc. discovers, develops and commercializes therapeutics with enhanced pharmaceutical properties that are active against a broad range of viral diseases. Leveraging a powerful lipid, prodrug technology, ProLipTag(TM), Chimerix is able to develop drug candidates with oral-availability, increased potency and targeted delivery. These enhanced pharmaceutical properties can be applied to new drug moieti
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Carrington Subsidiary DelSite Initiates Critical Toxicology Studies of Its Nasal Powder Bird Flu Vaccine
2. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
6. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
7. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Prolexys Pharmaceuticals Initiates Phase 1 Study
10. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
11. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Accuray Incorporated (Nasdaq: ARAY ), a global ... its president and chief executive officer, Euan S. Thomson, ... J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ... ,, A live webcast of each presentation will ... the Company,s Web site at http://www.accuray.com . ...
(Date:12/16/2009)... DATATRAK International, Inc. (OTCQX: DATA), ... global eClinical solutions for the clinical trials ... version 9.0 eClinical Software. This release ... and service delivery and introduces two new ... the DATATRAK Learning Center(TM) and the DATATRAK ...
(Date:12/16/2009)... -- HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) an online ... million in 12% per annum short term debt financing. ... initial drawdown of $500,000, with accrued interest and principal ... with accrued interest and principal repayable in one year ... cashflow positive for any calendar month prior to December ...
Breaking Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2National Alliance for Hispanic Health Applauds Confirmation of Sonia Sotomayor as the Nations 111th Supreme Court Justice 53920 1Hill Rom Reports Third Quarter Financial Results 53916 1Hill Rom Reports Third Quarter Financial Results 53916 2Hill Rom Reports Third Quarter Financial Results 53916 3Hill Rom Reports Third Quarter Financial Results 53916 4Hill Rom Reports Third Quarter Financial Results 53916 5Hill Rom Reports Third Quarter Financial Results 53916 6Hill Rom Reports Third Quarter Financial Results 53916 7Hill Rom Reports Third Quarter Financial Results 53916 8Hill Rom Reports Third Quarter Financial Results 53916 9Hill Rom Reports Third Quarter Financial Results 53916 10Hill Rom Reports Third Quarter Financial Results 53916 11Hill Rom Reports Third Quarter Financial Results 53916 12Hill Rom Reports Third Quarter Financial Results 53916 13Hill Rom Reports Third Quarter Financial Results 53916 14Hill Rom Reports Third Quarter Financial Results 53916 15Hill Rom Reports Third Quarter Financial Results 53916 16Hill Rom Reports Third Quarter Financial Results 53916 17Hill Rom Reports Third Quarter Financial Results 53916 18AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 1AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 2AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 3AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 4AutoImmune Inc Reports 2009 Second Quarter Financial Results 13438 5
(Date:12/17/2009)... Motionsoft, Inc. announced today that it ... (PCI) Data Security Standards (DSS) certification, making it ... in the health and wellness space that has ... is the result of a collaborative effort formed ... International, MasterCard Worldwide, American Express, Discover Financial Services ...
(Date:12/17/2009)... PHILADELPHIA, Dec. 17 The recently opened ... already out in the community in full force this ... Run on December 13th, benefiting the Arthritis Foundation, a ... of arthritis. The event boasted 1,500 attendees, spotlighting LSI,s ... Run is a renowned, national fundraiser and a festive ...
(Date:12/17/2009)... and glutathione S-transferase T1 (GSTT1) null genotypes have been ... regarding the association between GSTM1 and GSTT1 null genotypes ... However, the majority of previous reports are limited by ... GSTM1/GSTT1 null genotype with the risk of GC and ... numbers of samples. , A research article to ...
(Date:12/17/2009)... DIEGO (December 17, 2009) Researchers from the ... aim at several of the world,s most dangerous infectious ... a five-year, $18.8 million federally-funded set of projects seeking ... , The Institute received four project awards ... and Infectious Diseases (NIAID), part of the National Institutes ...
(Date:12/17/2009)... one day provide therapeutic options for muscle and bone ... the umbilical cord, just as the blood that goes ... disorders, said University of Pittsburgh School of Medicine researchers ... Journal of Biomedicine and Biotechnology . , Umbilical ... are remarkably stable and might not trigger strong immune ...
Breaking Medicine News(10 mins):Health News:Motionsoft Completes PCI Compliance Certification 2Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 2Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 3Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 4Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 5Health News:Umbilical cord could be new source of plentiful stem cells, say Pitt researchers 2
... to the memory and scientific accomplishments of Dr. Judah ... and shed light on the link between blood supply ... (Volume 6, Number 3-4) of Lymphatic Research and ... the research impact of one of the pre-eminent physician-scientists ...
... a child born with cleft lip and palate often have ... a normal life. For some, this year,s resolution will ... philanthropy, members of the American Society of Plastic Surgeons (ASPS) ... give than to receive," by traveling overseas on behalf of ...
... Calif., Jan. 7 The surgical lights are on, ... West Coast,s most,advanced pediatric surgery center, at Lucile Packard ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090107/AQW023 ) , ... in December, provide the,latest in imaging and communication technologies, ...
... ZMH ; SWX: ZMH) announced today it will be ... on January 13, 2009,at 12:00 p.m. Eastern Time. , ... via Zimmer,s Investor,Relations website at http://investor.zimmer.com . The webcast ... About the Company , Founded in ...
... admission PHILADELPHIA, Jan. 7 /PRNewswire/ -- ... year,s Healthy Kids Fest on Sunday, January 11, 2009, at ... to 5 p.m. Just in time for those New Year,s ... and free activities for the whole family.The Blue Cross RiverRink ...
... L.P. today announced that it has settled a lawsuit brought ... in October 2005 pertaining to Medicaid reimbursements paid by the ... a full release of claims, Dey has agreed to pay ... 2007 acquisition agreement between Mylan Inc. (Dey,s parent company) and ...
Other Medicine News:Health News:Festschrift Issue honoring Judah Folkman, M.D., in Lymphatic Research and Biology 2Health News:New year brings new hope to children born with cleft lip, palate 2Health News:Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center 2Health News:Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center 3Health News:Packard Children's Opens West Coast's Most Advanced Pediatric Surgery Center 4Health News:Families Encouraged to Enjoy Healthy Kids Fest at the Blue Cross RiverRink January 11 2Health News:Dey L.P. Settles State of Mississippi Pricing Litigation 2
... MJS anatomic knee system ... durability, minimize polyethylene wear ... to minimize contact stress ... to achieve a well ...
The Balanced Knee™ system provides instrumentation designed to achieve proper tissue balancing and alignment with user-friendly instrumentation that provides reproducible results....
... a cruciate sparing version which provides ... both resurfacing and inset patellas. Precision ... and fit with tibial articular surface ... cutting guide peg locations provide easy ...
... a femoral option and tibial insert which provides ... 60 degrees of flexion to induce a smooth ... degrees of flexion. Femoral component comes in a ... The constrained tibial insert in conjunction with the ...
Medicine Products: